Dimitris Papoutsakis

Title: Inventor Spotlight: Dimitris Papoutsakis

Introduction

Dimitris Papoutsakis is an accomplished inventor based in Acton, MA, known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Papoutsakis has made noteworthy advancements in medical treatments, particularly in the area of transplantation.

Latest Patents

Papoutsakis’s latest inventions include a new crystalline form of an acetate salt that may prove instrumental in the prevention or treatment of transplant rejection. Additionally, he developed a novel crystalline form (Form A) of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I). This invention encompasses pharmaceutical compositions comprising this crystalline form, processes for forming it, and its use in medical treatment.

Career Highlights

Dimitris is currently affiliated with Novartis AG, a leading global healthcare company. His research and development efforts at Novartis have not only expanded the company's innovative capabilities but have also contributed to the overall advancement of the pharmaceutical industry.

Collaborations

Throughout his career, Papoutsakis has worked alongside distinguished professionals, including Piotr Henryk Karpinski and Neil John Press. These collaborations have fostered a creative environment that enhances the development of groundbreaking medical solutions.

Conclusion

Dimitris Papoutsakis's innovative work in pharmaceutical inventions highlights his dedication to improving medical treatments. His patents exemplify the critical role of inventors in advancing healthcare and showcasing the importance of research and collaboration within the industry. As he continues to push the boundaries of scientific innovation, Papoutsakis remains a prominent figure in the field of pharmaceuticals.